RecallRadar

FDA Device recall Z-0547-2014

FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA. FastPack Total PSA Immunoassay is a paramagnetic p…

On 2013-12-25 the FDA classified a Class II recall of FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA. FastPack Total PSA Immunoassay is a paramagnetic p… by Qualigen, citing qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0547-2014
ClassificationClass II
Statusterminated
Initiated2013-11-08
Published2013-12-25
Last updated2026-09-13 11:53 UTC
CompanyQualigen
DistributionAL, CA, IN, KS, KY, MA, NC, NV, NY, OK, SC, TN, TX, UT, VA, WA

Product

FastPack Total PSA Immunoassay Chemilunescence assay for the determination of Total PSA. FastPack Total PSA Immunoassay is a paramagnetic particle immunoassay for the in vitro quantitative determination of prostate-specific antigen (PSA) in human serum and plasma as an aid in the management of patients with prostate cancer. The FastPack Total PSA Immunoassay is designed for use with the FastPack System.

Reason

Qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect.

Identifiers

code_infoTotal PSA: Catalog Number 25000040. Lot Number 1309038-10P Exp Date 6/26/2013.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0547-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.